NantKwest, Inc. (NK): Price and Financial Metrics

NantKwest, Inc. (NK): $32.49

4.21 (+14.89%)

POWR Rating

Component Grades













Add NK to Watchlist
Sign Up

Industry: Biotech



in industry

NK Stock Price Chart Interactive Chart >

Price chart for NK

NK Price/Volume Stats

Current price $32.49 52-week high $45.42
Prev. close $28.28 52-week low $2.52
Day low $29.74 Volume 1,109,000
Day high $33.15 Avg. volume 1,568,129
50-day MA $22.98 Dividend yield N/A
200-day MA $12.74 Market Cap 3.55B

NantKwest, Inc. (NK) Company Bio

NantKwest is a clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. The company was founded in 2002 and is based in Cardiff-by-the-Sea, California.

NK Latest News Stream

Event/Time News Detail
Loading, please wait...

NK Latest Social Stream

Loading social stream, please wait...

View Full NK Social Stream

Latest NK News From Around the Web

Below are the latest news stories about NantKwest Inc that investors may wish to consider to help them evaluate NK as an investment opportunity.

ImmunityBio and NantKwest Complete Merger

ImmunityBio, Inc. and NantKwest, Inc. (NASDAQ: NK), today announced the completion of their previously announced 100% stock-for-stock merger. This follows the satisfaction of all customary closing conditions, including approval of the merger by a majority of unaffiliated shareholders of NantKwest at its Special Meeting held on March 8, 2021. The combined company will operate under the name ImmunityBio, Inc. ("ImmunityBio") and its shares of common stock will commence trading on NASDAQ on March 10, 2021 under the new ticker "IBRX."

Yahoo | March 9, 2021

NantKwest's Charts Are Extended When Compared to the Popular Moving Averages

During Friday's "Lightning Round" segment of Mad Money, one caller quizzed Jim Cramer about NantKwest . In this daily bar chart of NK, below, we can see that prices made a base down in the $5 area before rallying in December and soaring into February. NK is trading above the rising 50-day moving average line and is extended (overbought) when compared to the rising 200-day line which intersects down at only $12.

Yahoo | March 1, 2021

INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - CTB, PBCT, HMSY, NK, SPWH

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Yahoo | February 23, 2021

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Merger Investigation

WILMINGTON, Del., Feb. 20, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating: NantKwest, Inc. (NASDAQ GS: NK) regarding possible breaches of fiduciary duties and other violations of law related to NantKwest’s agreement to merge with ImmunityBio, Inc. To learn more about this investigation and your rights, visit: Cardtronics plc (NASDAQ GS: CATM) regarding possible breaches of fiduciary duties and other violations of law related to Cardtronics’ agreement to be acquired by affiliates of Apollo Global Management, Inc. and Hudson Executive Capital LP. To learn more about this investigation and your rights, visit: Landcadia Holdings III, Inc. (NASDAQ GS: LCYAU) regardin...

Yahoo | February 20, 2021

INVESTIGATION ALERT: Halper Sadeh LLP Investigates AEGN, FFG, NK, GWPH; Shareholders Are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / February 20, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:Aegion Corporation (NASDAQ:AEGN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to affiliates of New Mountain Capital, L. If you are an Aegion shareholder, click here to learn more about your rights and options.

Yahoo | February 20, 2021

Read More 'NK' Stories Here

NK Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year 414.08%
5-year 659.11%
2022 N/A
2021 0.00%
2020 251.72%
2019 226.72%
2018 -74.16%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6269 seconds.